论文部分内容阅读
目的研究间变性淋巴瘤激酶(ALK)基因重组和表皮生长因子受体(EGFR)突变的晚期肺腺癌病人CT影像特征的差异。材料与方法此回顾性研究经伦理委员会批准,
Objective To study the difference of CT features in patients with advanced lung adenocarcinoma who had ALK gene mutation and epidermal growth factor receptor (EGFR) mutation. Materials and Methods This retrospective study was approved by the Ethics Committee,